Epidemiología de la hiperplasia benigna de próstata: Definición de enfermedad

Revista Clinica Espanola

Volumn 199, Issue SUPPL. 2, 1999, Pages 12-18

  Molero, J A Chicharro ^a   Rodríguez, R Burgos ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007440384     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride or both in benign prostatic hyperplasia. N Engl J Med 1996; 335:533-539.
2. Boyle P, Gould AL, Roehborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. Urology 1996;398-405.
3. McPherson K, Wennberg JE, Hoving OB, Clifford P. Small area variations in the use of common surgical procedures: an international comparison of New England, England and Norway. N Engl J Med 1982; 307: 1.310-1.314.
4. Barry MJ. Physicians takin the lead. Health Manage Q 1991; 13(2):20-23.
5. Hunter DJW, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 1996; 155:1.965.
6. Sagnier PP, MacFarlane G, RIchard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol 1994; 151:1.266.
7. Tuskamoto T, Kumamoto Y, Masumori N, et al. Prevalence of prostatin in Japanese men in a comunity-based study with comparison to a similar American study. J Urol 1995; 154:391.
8. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150:85.
9. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. The Lancet 1991; 338:469.
10. Berry SJ, Coffey DS, Walsh PC. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474.
11. Ruud-Bosch JL, Hop CJ, Kirkles WJ, Schröder FH. Natural history of benign prostatic hyperplasia: appropiate case definition and estimation of its prevalence in the community. Urology 1995; 46(suppl 3):34.
12. Chicharro-Molero JA, Burgos-Rodríguez R, Sánchez-Cruz JJ, Del Rosal-Samaniego JM, Rodero-García P, Rodríguez-Vallejo JM. Prevalence of BPH in Spanish men aged above 40 years. J Urol 1998; 159:878-882.
13. Chicharro-Molero JA, Burgos-Rodríguez. Epidemiología de la HBP. Medicine 1997; sep:3:8.